CIM
APRE icon

Coastal Investment Management’s Aprea Therapeutics APRE Stock Holding History

Coastal Investment Management’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$214K Hold
2,098
– – 0.3% 12
2021
Q2 		$205K Hold
2,098
– – 0.33% 16
2021
Q1 		$214K Hold
2,098
– – 0.37% 17
2020
Q4 		$206K Buy
+2,098
New +$998K 0.38% 19
2020
Q1 		– Sell
-250
Closed -$229K – 9
2019
Q4 		$229K Buy
+250
New +$138K 0.17% 12

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Coastal Investment Management's APRE Position: Q3 2021 in Review

Coastal Investment Management held its Aprea Therapeutics (APRE) position steady in Q3 2021 at 2,098 shares worth $214K. The position accounts for 0.3% of the portfolio, ranked #12.

Coastal Investment Management first reported a position in APRE in Q4 2019 and has held it in 5 quarters since. The position peaked at $229K in Q4 2019. 39 funds tracked by Wall St. Rank hold APRE as of Q3 2021.

  • Coastal Investment Management held 2,098 shares of Aprea Therapeutics worth $214K as of Q3 2021.
  • Coastal Investment Management left its Aprea Therapeutics share count unchanged in Q3 2021.
  • Aprea Therapeutics made up 0.3% of Coastal Investment Management's portfolio in Q3 2021, its #12 holding.
  • Coastal Investment Management first reported a position in Aprea Therapeutics in Q4 2019 and has held it in 5 quarters since.
  • Coastal Investment Management's Aprea Therapeutics position peaked at $229K in Q4 2019.
  • 39 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2021.

Based on Coastal Investment Management's 13F filing for Q3 2021, filed 18 Oct 2021.